Increased nuclear DNA oxidation in the brain in Alzheimer' s disease

Journal of Neurochemistry

Volumn 71, Issue 5, 1998, Pages 2034-2040

  Gabbita, S Prasad ^a   Lovell, Mark A ^a,b   Markesbery, William R ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; DNA oxidation; Gas chromatography mass spectrometry; Oxidative stress

Indexed keywords

CELL NUCLEUS DNA;

ALZHEIMER DISEASE; ARTICLE; CELL NUCLEUS; DNA DEGRADATION; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0031754202     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71052034.x     Document Type: Article

References (39)

1. Beal M. F. (1994) Energy, oxidative damage, Alzheimer's disease: clues to the underlying puzzle. Neurobiol. Aging 15, S171-S174.
2. Beckman K. and Ames B. N. (1997) Oxidative decay of DNA. J. Biol. Chem. 272, 19633-19636.
3. Cornett C. R., Markesbery W. R., and Ehmann W. D. (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brains. Neurotoxicology 19, 339-346.
4. Diebel M. A., Ehmann W. D., and Markesbery W. R. (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 143, 137-142.
5. Dizdaroglu M. (1993) Quantitative determination of oxidative base damage in DNA by stable isotope-dilution mass spectrometry. FEBS Lett. 315, 1-6.
6. Dizdaroglu M., Rao G., Halliwell B., and Gajewski E. (1991) Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch. Biochem. Biophys. 285, 317-324.
7. Douki T., Delatour T., Bianchini F., and Cadet J. (1996) Observation and prevention of an artifactual formation of oxidized DNA bases and nucleosides in the GC-EIMS method. Carcinogenesis 17, 347-353.
8. Ehmann W. D., Markesbery W. R., Alauddin M., Hossam T. I. M., and Brubaker E. H. (1986) Brain trace elements in Alzheimer's disease. Neurotoxicology 7, 197-206.
9. Good P. F., Perl D. P., Bierer L. M., and Schmeidler J. (1992) Selective accumulation of aluminum and iron in neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31, 286-292.
10. Good P. F., Werner P., Hsu A., Olanow C. W., and Perl D. P. (1996) Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 21-28.
11. Halliwell B. (1990) How to characterize a biological antioxidant. Free Radic. Res. Commun. 9, 1-32.
12. Halliwell B. and Dizdaroglu M. (1992) The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic. Res. Commun. 16, 75-87.
13. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Lovell M., Markesbery W. R., and Butterfield D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
14. Hyman B. T., Tanzi R. E., Marzloff K., Barbour R., and Schenk D. (1992) Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 51, 76-83.
15. Lovell M. A., Ehmann W. D., Butler S. M., and Markesbery W. R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
16. Lovell M. A., Ehmann W. D., Mattson M. P., and Markesbery W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457-461.
17. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., and Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. (in press).
18. Lyras L., Cairns N. J., Jenner A., Jenner P., and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
19. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
20. Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 33-36.
21. McKhann G. D., Drachman D. A., Holstein M. F., Katzman R., Price D., and Stadlan E. M. (1991) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 41, 479-486.
22. Mecocci P., MacGarvey U., Kaufmann A. E., Koontz D., Shoffner J. M., Wallace D., and Beal M. F. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34, 609-616.
23. Mecocci P., MacGarvey U., and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
24. Merril C. R., Zullo S., Ghanbari H., Herman M. M., Kleinman J. E., Bigelow L. B., Bartko J. J., and Sabourin D. J. (1996) Possible relationship between conditions associated with chronic hypoxia and brain mitochondrial DNA deletions. Arch. Biochem. Biophys. 326, 172-177.
25. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Cram B. J., Brownlee L. M., Vogel F. S., Hughes J. P., Van Belle G., and Berg L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
26. Montine T. J., Amarnath V., Martin M. E., Strittmatter W. J., and Graham D. G. (1996) E-4-Hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 184, 89-93.
27. National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18, S1-S2.
28. Prasad M. R., Lovell M. A., Yatin M., Dhillon H., and Markesbery W. R. (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23, 81-88.
29. Ravanat J., Turesky R. J., Gremaud E., Trudel L. J., and Stadler R. H. (1995) Determination of 8-oxoguanine by gas chromatography-mass spectrometry and HPLC-electrochemical detection: over-estimation of the background level of the oxidized base by the gas chromatography-mass spectrometry assay. Chem. Res. Toxicol. 8, 1039-1045.
30. Samudralwar D. L., Diprete C. C., Ni B.-F., Ehmann W. D., and Markesbery W. R. (1995) Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130, 139-145.
31. Sayre L. M., Zelasko D. A., Harris P. L. R., Perry G., Salomon R. G., and Smith M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097.
32. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
33. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stern D., Sayre L. M., Monnier V. M., and Perry G. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91, 5710-5714.
34. Smith M. A., Sayre L. M., Anderson V. E., Beal M. F., Kowall N., Richey P. L., and Perry G. (1996) Oxidative damage in Alzheimer's disease. Nature 382, 120-121.
35. Smith M. A., Harris P. L., Sayre L. M., Beckman J. S., and Perry G. (1997a) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 2653-2657.
36. Smith M. A., Harris P. L., Sayre L. M., and Perry G. (1997b) Iron accumulation in Alzheimer's disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94, 9866-9868.
37. Svennerholm L. and Gottfries C. G. (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type 1) and demyelination in late-onset form (type II). J. Neurochem. 62, 1039-1047.
38. Te Koppele J. M., Lucassen P. J., Sakkee A. N., Van Asten J. G., Ravid R., Swaab D. F., and Van Bezooijen C. F. (1996) 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease. Neurobiol. Aging 17, 819-826.
39. Yan S. D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y. S., Scott C. W., Caputo C., Frappier T., Smith M. A., Perry G., Yen S. H., and Stern D. (1994) Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA 91, 7787-7791.